Recruitment of casein kinase 2 is involved in aβpp processing following cholinergic stimulation

Journal of Alzheimer's Disease

Volumn 20, Issue 4, 2010, Pages 1133-1141

  Lenzken, Silvia C ^a   Stanga, Serena ^a   Lanni, Cristina ^a   De Leonardis, Fabio ^b   Govoni, Stefano ^a   Racchi, Marco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Alzheimer's disease; amyloid protein precursor; casein kinase 2; cholingergic; neuroblastoma; protein kinase C; signal transduction

Indexed keywords

ADAM 17 PROTEIN; ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; AMYLOID PRECURSOR PROTEIN; CARBACHOL; CASEIN KINASE II; CHOLINERGIC RECEPTOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C EPSILON; TUBULIN; UNCLASSIFIED DRUG; ADAM10 PROTEIN, HUMAN; CHOLINERGIC RECEPTOR STIMULATING AGENT; MEMBRANE PROTEIN; MUSCARINIC AGENT; SECRETASE; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNODETECTION; IMMUNOPRECIPITATION; METABOLIC REGULATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; CELL LINE; CHOLINERGIC SYSTEM; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

ADAM PROTEINS; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; BLOTTING, WESTERN; CARBACHOL; CASEIN KINASE II; CELL LINE; CHOLINERGIC AGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MUSCARINIC AGONISTS; PARASYMPATHETIC NERVOUS SYSTEM; PROTEIN KINASE C-EPSILON; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUBULIN;

EID: 77954556903     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-090232     Document Type: Article

References (31)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
2. Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN (2004) The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol Res 50, 397-409.
3. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273, 27765-27767.
4. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F (1999) Constitutive and regulated alpha secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96, 3922-3927.
5. Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM (2000) Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J Biol Chem 275, 2568-2575.
6. Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O, Annaert W, Saftig P, Hartmann D, De Strooper B (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS- 9, ADAMS-15, and the gamma-secretase. J Biol Chem 17, 11738-11747.
7. Racchi M, Govoni S (1999) Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism. Trends Pharmacol Sci 20, 418-423. (Pubitemid 29450364)
8. Racchi M, Govoni S (2003) The pharmacology of amyloid precursor protein processing. Exp Gerontol 38, 145-157.
9. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
10. Racchi M, Mazzucchelli M, Porrello E, Lanni C, Govoni S (2004) Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacol Res 50, 441-451.
11. Lahiri DK, Rogers JT, Greig NH, Sambamurti K (2004) Rationale for the development of cholinesterase inhibitors as anti- Alzheimer agents. Curr Pharm Des 10, 3111-3119.
12. Pakaski M, Kasa P (2003) Role of acetylcholinesterase inhibitors in the metabolism of amyloid precursor protein. Curr Drug Targets CNS Neurol Disord 2, 163-171.
13. Lanni C, Mazzucchelli M, Porrello E, Govoni S, Racchi M (2004) Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein. Eur J Biochem 271, 3068-3075.
14. Meggio F, Pinna L (2003) One-thousand-and-one substrates of protein kinase CK2? FASEB J 17, 349-368.
15. Blanquet PR (2000) Casein kinase 2 as a potentially important enzyme in the nervous system. Prog Neurobiol 60, 211-246.
16. Sanghera JS, Charlton LA, Paddon HB, Pelech SL (1992) Purification and characterization of echinoderm casein kinase II - Regulation by protein kinase C. Biochem J 283, 829-837.
17. Silva-Neto MA, Carneiro AB, Vieira DP, Mesquita RD, Lopes AH (2002) Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. Biochem Biophys Res Comm 293, 1358-1363.
18. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, Snyder SH (2003) Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40, 129-137.
19. Soh JW, Lee EH, Prywes R, Weinstein IB (1999) Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19, 1313-1324.
20. Kinouchi T, Sorimachi H, Maruyama K, Mizuno K, Ohno S, Ishiura S, Suzuki K (1995) Conventional protein kinase C (PKC)-alpha and novel PKC epsilon, but not -delta, increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts. FEBS Lett 364, 203-206.
21. Yeon SW, Jung MW, Ha MJ, Kim SU, Huh K, Savage MJ, Masliah E, Mook-Jung I (2001) Blockade of PKC epsilon activation attenuates phorbol ester-induced increase of alphasecretase- derived secreted form of amyloid precursor protein. Biochem Biophys Res Commun 280, 782-787.
22. Zhu G,Wang D, Lin YH, McMahon T, Koo EH, Messing RO (2001) Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase. Biochem Biophys Res Commun 285, 997-1006.
23. Racchi M, Mazzucchelli M, Pascale A, Sironi M, Govoni S (2003) Role of protein kinase Calpha in the regulated secretion of the amyloid precursor protein. Mol Psychiatry 8, 209-216.
24. Csukai M, Chen CH, De Matteis MA,Mochly-Rosen D (1997) The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. J Biol Chem 272, 29200-29206. (Pubitemid 27498211)
25. Brandman R, Disatnik MH, Churchill E, Mochly-Rosen D (2007) Peptides derived from the C2 domain of protein Kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces. J Biol Chem 282, 4113-4123.
26. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella- Deana A, Shugar D, Pinna LA (2001) Selectivity of 4,5,6,7- tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett 496, 44-48.
27. Zimmermann M, Gardoni F, Marcello E, Colciaghi F, Borroni B, Padovani A, Cattabeni F, Di Luca M (2004) Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem 90, 1489-1499.
28. Alfa Cisse M, Sunyach C, Slack BE, Fisher A, Vincent B, Checler F (2007) M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J Neurosci 27, 4083-4092.
29. Hwang EM, Kim SK, Sohn JH, Lee JY, Kim Y, Kim YS, Mook-Jung I (2006) Furin is an endogenous regulator of alphasecretase associated APP processing. Biochem Biophys Res Commun 349, 654-659.
30. Tuazon PT, Traugh JA (1991) Casein kinase I and II- multipotential serine protein kinases: structure, function, and regulation. Adv Second Messenger Phosphoprotein Res 23, 123-164.
31. Jones BG, Thomas L, Molloy SS, Thulin CD, Fry MD,Walsh KA, Thomas G (1995) Intracellular trafficking of furin is modulated by the phosphorylation state of a casein kinase II site in its cytoplasmic tail. EMBO J 14, 5869-5883.